🇺🇸 FDA
Patent

US 8507672

Substituted pyrrolo[2,3-d]pyrimidines as LIM kinase 2 inhibitors

granted A61PA61P25/00A61P27/02

Quick answer

US patent 8507672 (Substituted pyrrolo[2,3-d]pyrimidines as LIM kinase 2 inhibitors) held by LEXICON PHARMACEUTICALS, INC. expires Mon Aug 08 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
LEXICON PHARMACEUTICALS, INC.
Grant date
Tue Aug 13 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 08 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61P, A61P25/00, A61P27/02, A61P27/06, A61P29/00